Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 1996

View Archived Issues

Therapeutically active cysteine proteinase inhibitors described by Synphar

Roussel Uclaf reports new quinoline derivatives

NK1 antagonists described by Boehringer Ingelheim

Novel 5-HT4 receptor agonist claimed by Pharmacia & Upjohn

Abbott reports on new PAF antagonists

Chugai reports new cholesterol-lowering compounds

New immunostimulant from Snow Brand

Antihypertensive peptides disclosed by Snow Brand

Novel mechanism of action reported for Xenova PAI inhibitor

Myriad Genetics announces research collaboration

Encouraging clinical results with MacroChem Rx for impotence

BioDelivery Sciences and Wyeth-Lederle Vaccines collaboration

Atlantic Pharmaceuticals issued U.S. patent

Positive phase IIa results for therapeutic vaccine for genital warts

PLC Systems allowed to expand Heart Laser trials

ADAC's Molecular Coincidence Detection shows promising results

Visible Genetics acquires BIOS Laboratories technology

RSV MAb from MedImmune enters pivotal trials

Biomira strengthens patent rights to Mucin 1 cancer antigen

5-LO inhibitor approved by FDA

NDA filed for Antizol

Taxotere now approved in 44 countries

Glaxo Wellcome evaluates new alpha1a-adrenoceptor antagonist

BioProCon to market DiagnoCure bladder cancer diagnostic

New HIV-1 protease inhibitor in development at LG Chemical

New ET antagonist in preclinical testing at Parke-Davis

Vertex selects lead development candidate for autoimmune diseases

Ivax generic cardiovascular drug approved in U.S.

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Faulding receives approval for generic contrast media

DuPont Merck evaluates new candidate cognition enhancer

Oral butyrate prodrug in preclinical testing at Vertex

Advisory committee recommends approval of non-nicotine smoking cessation product

First marketing approval for Allergan antipsoriatic

BMS in-licenses antifungal triazole from Eisai

FDA panel recommends approval of BeneFix

Nortran's antiarrhythmic agents receive patent protection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...